Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 21

Trial Status

Completed5
Terminated1

Role Distribution

Principal Investigator5
Other Roles1
PI Rate83%

Activity Timeline

Clinical Trials (6)

NCT00449280Phase 1Completed
Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies
Advanced Solid Tumor
Principalinvestigator
NCT00619242Not ApplicableTerminated
The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer
Esophageal Cancer
Principalinvestigator
NCT00667485Phase 1Completed
Rapamycin Plus Bevacizumab in Advanced Cancers
Advanced CancerMetastatic Cancer
Principalinvestigator
NCT00708591Phase 1Completed
Study of Rapamycin Plus Ketoconazole in Advanced Cancers
Advanced Cancer
Principalinvestigator

Research Network

Collaboration Network

4 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Advanced CancerAdvanced Solid TumorCancer of Esophagus
Similarity Score15%

James L Gulley, M.D.

National Cancer Institute (NCI)

Related
18 trials

Shared therapeutic areas:

Solid TumorsAdvanced Solid TumorMetastatic Cancer
Similarity Score15%

Aung Naing, Md

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Solid TumorsAdvanced CancerMetastatic Cancer
Similarity Score15%

lin shen

Peking University Cancer Hospital & Institute

Related
31 trials

Shared therapeutic areas:

Advanced Solid TumorCancer of EsophagusSolid Tumors
Similarity Score15%

Amar Patel, MD

Celgene

Related
5 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

Celgene
Collaborated on 1 trial
Similarity Score14%

Robert Ferris, MD, PhD

University of Pittsburgh

Related
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

Celgene
Collaborated on 1 trial
Similarity Score14%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Metastatic CancerSolid Tumors
Similarity Score10%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Cancer of EsophagusMetastatic Cancer
Similarity Score10%

yuankai shi, MD

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Related
17 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckCancer of Esophagus
Similarity Score10%

Nancy Lee, MD

Memorial Sloan Kettering Cancer Center

Related
18 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckMetastatic Cancer
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT01836029Phase 2StudyChair

Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Carcinoma, Squamous Cell of Head and Neck
Completed
NCT00449280Phase 1PrincipalInvestigator

Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies

Advanced Solid Tumor
Completed
NCT00583063Early Phase 1PrincipalInvestigator

Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers

Solid Tumors
Completed
NCT00619242Not ApplicablePrincipalInvestigator

The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer

Esophageal Cancer
Terminated
NCT00667485Phase 1PrincipalInvestigator

Rapamycin Plus Bevacizumab in Advanced Cancers

Advanced CancerMetastatic Cancer
Completed
NCT00708591Phase 1PrincipalInvestigator

Study of Rapamycin Plus Ketoconazole in Advanced Cancers

Advanced Cancer
Completed

All 6 trials loaded